title: PET and functional anatomic fusion imaging in lung and breast cancers.
abstract: Metabolic imaging with PET is an established adjunct to anatomic imaging methods in patients with bronchial and breast cancers. The functional anatomic fusion imaging with PET/CT can further improve staging and restaging of patients. PET/CT can influence the planning of a surgical intervention or radiation treatment at staging and in patients with suspected locoregional recurrence. The use of a PET/CT whole body imaging protocol may identify extended disease earlier than conventional imaging methods and thus influence treatment decisions.
authors.affiliation: Division of Nuclear Medicine, University Hospital, Zurich, Switzerland. gerhard.goerres@dmr.usz.ch
authors.forename: Gerhard W
authors.initials: GW
authors.lastname: Görres
authors.forename: Hans C
authors.initials: HC
authors.lastname: Steinert
authors.forename: Gustav K
authors.initials: GK
authors.lastname: von Schulthess
mesh_terms: D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D011856:Radiographic Image Enhancement; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18